Free cash flow deficits have accelerated to $8.4 million in 2026Q3, driven by rising capital expenditures of $1.2 million and persistent operational cash outflows.
| Metric | TTM | Mar'25 | Mar'24 | Mar'23 | Mar'22 | Mar'21 | Mar'20 | Mar'19 | Mar'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 | Jun'08 | Jun'07 | Jun'06 | Jun'05 | Jun'04 |
|---|
| Cash from Operations | -22.25M | -15.72M | -13.95M | -11.01M | -10.26M | -5.91M | -4.09M | -1.81M | -791.13K | -94.81K | -10.66K | 0 | 0 | 0 | -17.49K | -6.72K | 0 | 0 | -76 | -84 |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -192.81% | -12.67% | -26.7% | -7.33% | -73.64% | -44.3% | -126.49% | -128.53% | -734.44% | -789.15% | - | - | - | 100% | -160.45% | - | - | 100% | 9.52% | - |
| Net Income | -26.78M | -18.82M | -17.47M | -13.88M | -18.63M | -7.38M | -5.32M | -2.54M | -659.25K | -106.56K | -31.08K | -30.99K | -22.79K | -20.79K | -17.49K | -6.72K | -6.48K | -8.91K | -14.29K | -6.21K |
| Depreciation & Amortization | 1.56M | 1.06M | 768K | 152.4K | 117.49K | 181.84K | 35.43K | 14.47K | 1.86K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 2.44M | 2.38M | 2.7M | 2.72M | 4.03M | 1.23M | 801.24K | 532.11K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | -341.86K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 140K | 52K | 143K | 202.67K | 3.85M | 121.04K | 341.86K | 19.8K | 3.72K | -3 | 0 | -2 | 2 | 0 | -17.49K | -6.72K | 0 | 1.5K | 1.5K | 0 |
| Working Capital Changes | 389K | -392K | -94K | -211.82K | 374.99K | -61.15K | 389.36K | 165.19K | -133.75K | 11.75K | 20.42K | 30.99K | 22.79K | 20.79K | 17.49K | 6.72K | 6.48K | 7.41K | 12.71K | 6.12K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 593K | 0 | 458K | -200.76K | 0 | 0 | 530.25K | 0 | -109.75K | 0 | 0 | -1.55K | 1.55K | 0 | -578 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -3.88M | -2.49M | -1.7M | -1.64M | -54.76K | -109.67K | -260.79K | -77.12K | -15.33K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | -3.88M | -2.49M | -1.7M | -1.64M | -54.76K | -109.67K | -260.79K | -77.12K | -15.33K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -213 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 22.07M | 22.08M | 21.09M | 7.37M | 17.92M | 4.36M | 923.99K | 4.14M | 4.71M | 1.47M | 10.66K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 4.14M | 2.58M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 22.07M | 20.82M | 20.34M | 7.37M | 13.79M | 1.79M | 923.99K | 4.14M | 4.73M | -14.1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14.1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 5K | 1.25M | 742K | -347 | 0 | 0 | 0 | -516 | -20.74K | 1.48M | 10.66K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -4.05M | 3.86M | 5.43M | -5.28M | 7.61M | -1.65M | -3.43M | 2.26M | 3.9M | 1.37M | 0 | 0 | 0 | 0 | -17.49K | -6.72K | 0 | 0 | -76 | -84 |
| Free Cash Flow | -26.12M | -18.21M | -15.65M | -12.65M | -10.31M | -6.02M | -4.36M | -1.89M | -806.46K | -94.81K | -10.66K | 0 | 0 | 0 | -17.49K | -6.72K | 0 | 0 | -76 | -84 |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -54.2% | -16.36% | -23.74% | -22.64% | -71.38% | -38.17% | -131.06% | -133.74% | -750.61% | -789.15% | - | - | - | 100% | -160.45% | - | - | 100% | 9.52% | - |
| FCF per Share | -11.89 | -14.76 | -20.98 | -34.88 | -45.45 | -29.07 | -21.94 | -10.23 | -5.44 | -2.44 | -0.77 | - | - | - | -1.26 | -0.48 | - | - | -0.01 | -0.02 |
| FCF Conversion (FCF/Net Income) | 0.98x | 0.84x | 0.80x | 0.79x | 0.55x | 0.80x | 0.77x | 0.71x | 1.20x | 0.89x | 0.34x | - | - | - | 1.00x | 1.00x | - | - | 0.01x | 0.01x |
| Interest Paid | 0 | 0 | 0 | 0 | 262K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 2K | 2K | 2K | 1.6K | 1.6K | 1.6K | 1.59K | 1.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Liquidity and regulatory dependency
As reported in financial statements, MODD's operating cash flow consistently tracks net losses, with the OCF/NI ratio fluctuating between 0.69 and 0.97, indicating that the company's cash outflows are fundamentally tied to its ongoing operational losses rather than significant non-cash accruals or working capital adjustments.
The tight correlation between net income and operating cash flow suggests that the company lacks the non-cash cushions often found in more mature entities. Investors should monitor this relationship, as the absence of meaningful accrual-based divergence implies that every dollar of loss is effectively a dollar of cash consumed.
Based on the provided quarterly data, the company's free cash flow trajectory has deteriorated from a $3.6 million deficit in 2024Q2 to an $8.4 million outflow by 2026Q3, reflecting an accelerating cash burn as the firm intensifies its pre-commercial development and infrastructure spending.
The widening FCF gap highlights the increasing financial pressure on the company as it approaches critical regulatory milestones. This trend suggests that the cost of maintaining the current development pace is rising, which may necessitate external funding sooner than previously anticipated by the market.
According to recent SEC filings, MODD's quarterly capital expenditures have trended upward, peaking at $1.2 million in 2026Q3, which underscores the company's transition toward building the manufacturing and testing infrastructure required to support a potential commercial launch of its modular insulin delivery platform.
This increase in capital intensity is a logical, albeit expensive, step for a pre-revenue medical device firm. Analysts should evaluate whether these investments in property and equipment will provide the necessary manufacturing yields to achieve future gross margin targets once the product reaches the market.
As indicated by historical data, the company has increasingly utilized stock-based compensation, which reached $813,000 in 2026Q2, serving as a critical non-cash lever to preserve limited cash reserves while simultaneously creating potential future dilution for shareholders during this high-risk pre-revenue development phase.
While SBC is a standard tool for talent retention in early-stage firms, its reliance suggests that the company is actively managing its cash runway by substituting equity for cash compensation. Investors should remain cautious, as this practice may obscure the true cost of operations and lead to significant equity dilution upon commercialization.
Quick answers to the most common questions about buying MODD stock.
Modular Medical, Inc. (MODD) generated $-15.7M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Modular Medical, Inc. (MODD) reported negative free cash flow of $18.2M in 2025, indicating capital requirements exceeded cash from operations.
Modular Medical, Inc. (MODD) spent $2.5M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.